The global Rabies Antiserum Market Growth Accelerated by increasing prevalence of animal rabies infections

 Rabies Antiserum is a solution derived from the blood of animals that have been immunized against rabies. It is administered to individuals who have high risk of developing rabies, such as those who have been bitten or scratched by an animal suspected of being infected.

The global Rabies Antiserum Market is estimated to be valued at US$ 1.24 Bn in 2023 and is expected to exhibit a CAGR of 3.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Rabies Antiserum neutralises the rabies virus to prevent the onset of disease in individuals exposed to the virus. The increasing prevalence of animal rabies infections has prompted greater prevention efforts through pre- and post-exposure prophylaxis using rabies biologics such as Rabies Antiserum.

Market key trends:
The growing prevalence of rabies infections among animals, particularly dogs, worldwide has been a major factor driving the increasing demand for rabies antiserum. According to the World Health Organization, rabies is endemic in over 150 countries and causes 60,000 human deaths annually. Domestic dogs serve as the major vector for rabies transmission to humans, accounting for over 99% of all rabies transmissions to humans. The high prevalence of animal rabies infections has necessitated greater availability and uptake of rabies antiserum for post-exposure prophylaxis in humans exposed to possibly rabid animals.
Segment Analysis
The global rabies antiserum market is dominated by the canine segment, which accounts for over 60% of the market share. This is because dogs are the primary vectors for rabies virus transmission to humans. The equine segment is expected to witness higher growth during the forecast period due to rising vaccination programs for horses against rabies virus in North America and Europe.

Key Takeaways
The global rabies antiserum market is expected to witness high growth during the forecast period driven by rising incidence of animal bites and focus of governments worldwide on preventing human rabies.

Regional analysis
Asia Pacific dominates the global rabies antiserum market and is expected to maintain its leading position during the forecast period. This is attributed to factors such as rising dog population, increased investment by governments in animal welfare programs, and growing human-animal conflict incidents in densely populated countries such as India and China.

Key players
Key players operating in the rabies antiserum market are CSL Behring, Sanofi Pasteur, Grifols S.A., Bharat Serum and Vaccines Ltd., Novartis AG, Kedrion Biopharma Inc., Biogenesis Bago SA, Serum Institute of India Ltd., Haffkine Bio-Pharmaceutical Corporation Ltd., Shanghai Institute of Biological Products Co. Ltd., CNBG (China National Biotec Group) Co. Ltd., Harbin Pharmaceutical Group Co. Ltd., Beijing Tiantan Biological Products Co. Ltd. CSL Behring dominates the global market owing to its diversified product portfolio and wide distribution network across developed markets.
_____________________________________________________

Comments

Post a Comment

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Image
The pituitary cancer market comprises of medical treatment options for patients diagnosed with pituitary cancer. Pituitary cancers are rare tumors that start in the pituitary gland which is a pea-sized gland located at the base of the brain.  The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.    Market key trends: One of the key trends fueling the growth of the pituitary cancer market is rising preference of targeted drug therapy over conventional chemotherapy. Targeted drug therapies mainly include somatostatin analogs and dopamine agonists which directly act on cancer cells and have less side effects compared to chemotherapy. These targeted drugs are effective in controlling symptoms and slowing tumor growth in patients with hormone secreting pituitary adenomas and carcinomas. The targe...
Read more

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Image
  Hospital beds play a crucial role in patient care, providing comfort, safety, and functionality for individuals requiring medical attention. Over the years, advancements in technology and design have revolutionized hospital beds, leading to improved patient outcomes and caregiver efficiency. From basic adjustable beds to sophisticated models equipped with cutting-edge features, the evolution of hospital beds has transformed the healthcare landscape. Evolution of Hospital Beds: Historically, hospital beds were simple in design, primarily consisting of a metal frame with adjustable height and manual controls. However, as medical practices advanced and patient needs became more complex, the demand for more versatile and ergonomic hospital beds grew. In recent decades, significant strides have been made in the development of hospital bed technology. Modern hospital beds are designed with a focus on patient comfort, safety, and mobility. Features such as electronic controls, motorize...
Read more

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management

Image
  Dry eye disease, also known as keratoconjunctivitis sicca, is a multifactorial disease of the ocular surface characterized by lack of sufficient moisture and tear film instability. Common symptoms of dry eye include stingy or burning sensation in eyes and blurred vision.   Market Dynamics : The Dry Eye Disease Market is witnessing high growth owing to rising awareness about disease management and increasing number of people experiencing symptoms of dry eyes. According to the report, increasing usage of electronic devices and prolonged screen time is a major driver fueling the demand for dry eye treatments. Additionally, growing geriatric population worldwide who are more prone to dry eyes is also contributing to the market growth. Availability of various treatment options along with new product launches is further expected to boost the market during forecast period.   Increasing Prevalence of Dry Eye Disease is Driving Market Growth   One of the major market drive...
Read more